CLINICAL_TRIALS
trial_result
· 2022-05-25
Clinical Trial Update: BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases [Phase 3]
Summary
Phase 3 trial update for BreCLIM-2 evaluating local treatment for breast cancer with liver metastases; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Umeå University | Conditions: Breast Cancer, Liver Metastases | Phase 3 | Status: RECRUITING